HopeStage
Back to all studies
RecruitingNCT06716996

Magnetic brain stimulation for mood symptoms after COVID

About this titleRead the official source — NCT06716996

This study assesses depression symptoms.

Device studyAges 18–65Switzerland
The study in practice

Understand this study

What is this study about?

This study assesses depression symptoms.

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
ZurichSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 14, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
52
Sponsor
Flurin Cathomas
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
Switzerland
Age range
From 18 Years to 65 Years
Official registry ID
NCT06716996
Official title
Show the full official title

Repeated Transcranial Magnetic Stimulation for the Treatment of Post-COVID Associated Affective Symptoms

Recruitment & locations

Currently recruiting

Zurich

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

This study assesses depression symptoms.

Who is behind this study?

The study sponsor is Flurin Cathomas.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies